WA
ABBV icon

WPG Advisers’s AbbVie ABBV Stock Holding History

WPG Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69.6K Sell
320
-6
-2% -$1.33K 0.05% 209
2025
Q4 		$74.5K Sell
326
-88
-21% -$20K 0.06% 217
2025
Q3 		$95.9K Buy
414
+4
+1% +$815 0.07% 171
2025
Q2 		$76.1K Sell
410
-81
-16% -$15.1K 0.06% 199
2025
Q1 		$103K Sell
491
-14
-3% -$2.72K 0.1% 159
2024
Q4 		$89.7K Buy
+505
New +$92.8K 0.08% 190

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WPG Advisers's ABBV Position: Q1 2026 in Review

WPG Advisers reduced its AbbVie (ABBV) stake by 1.8% in Q1 2026, selling an estimated $1.33K and leaving 320 shares worth $69.6K. The position accounts for 0.05% of the portfolio, ranked #209.

WPG Advisers first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $103K in Q1 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • WPG Advisers held 320 shares of AbbVie worth $69.6K as of Q1 2026.
  • WPG Advisers sold 6 AbbVie shares in Q1 2026, an estimated $1.33K.
  • AbbVie made up 0.05% of WPG Advisers's portfolio in Q1 2026, its #209 holding.
  • WPG Advisers first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • WPG Advisers's AbbVie position peaked at $103K in Q1 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on WPG Advisers's 13F filing for Q1 2026, filed 30 Apr 2026.